Top Markets
#1 Official Trump Official Trump +42.55%
#2 Melania Meme Melania Meme +24.96%
#3 Nockchain Nockchain +24.66%
#4 Wrapped STX (Velar) Wrapped STX (Velar) +21.17%
#5 Mubarak Mubarak +19.33%
#6 EXOD EXOD +18.93%
#7 Unit Pump Unit Pump +16.04%
#8 Pump.fun Pump.fun +15.99%
#9 Wrapped POL Wrapped POL +14.85%
#10 POL (ex-MATIC) POL (ex-MATIC) +13.79%
Coin of the day
Official Trump Official Trump
Configuración
Idioma
ESPAñOL
Moneda
USD
Tema
Mercury Biopharmaceutical Corporation Mercury Biopharmaceutical Corporation

Mercury Biopharmaceutical Corporation

6932
Clasificación en acciones #23452
Founded in 2019 and headquartered in New Taipei City, Taiwan, Mercury... Founded in 2019 and headquartered in New Taipei City, Taiwan, Mercury Biopharmaceutical Corporation is dedicated to creating innovative pharmaceutical solutions for medical conditions currently lacking adequate treatment options. A cornerstone of their strategy is the proprietary StackDose platform, an advanced drug development system designed to formulate novel medication delivery methods. This platform facilitates precisely timed drug release, targeted absorption at specific locations within the body, and flexible dosage modifications. The primary objective of StackDose is to significantly boost the bioavailability of active pharmaceutical ingredients, leading to a reduction in required drug dosages and fewer adverse effects. Their development pipeline currently addresses a variety of ailments, such as erectile dysfunction, pulmonary hypertension, sleep disturbances, benign prostatic hyperplasia, angina, migraines, hypertension, and pain management.
Precio por acción
$0.17616661
Última sincronización: 2026-08-21
Capitalización bursátil
$73.48M
Cambio (1 día)
0.18%
Cambio (1 año)
-37.76%
País
TW
Comercio Mercury Biopharmaceutical Corporation (6932)

Categoría

Healthcare
Ingresos de Mercury Biopharmaceutical Corporation (6932)
Ingresos en Aug 2026 TTM: 0
Según los últimos informes financieros de Mercury Biopharmaceutical Corporation, los ingresos actuales de la empresa (TTM) son 0. En 2026, la empresa obtuvo unos ingresos de 0 igual a los ingresos del año 2026, que fueron de 0. Los ingresos representan la cantidad total que una empresa genera por la venta de bienes o servicios. A diferencia de las ganancias, no se restan los gastos.
Historial de ingresos de Mercury Biopharmaceutical Corporation desde 2026 hasta 2026
Ingresos al final de cada año
Año Ingresos Cambiar
Not enough data for the provided dates.
Ingresos de empresas similares o competidoras
Empresa Ingresos Diferencia de ingresos País
MERCK Kommanditgesellschaft auf Aktien MERCK Kommanditgesellschaft auf Aktien
MERCK Kommanditgesellschaft auf Aktien
MER.SW
 - -
DE
Merck KGaA Merck KGaA
Merck KGaA
MRK.DE
 - -
DE
Takeda Pharmaceutical Company Limited Takeda Pharmaceutical Company Limited
Takeda Pharmaceutical Company Limited
4502.T
 - -
JP
Galderma Group AG Galderma Group AG
Galderma Group AG
GALD.SW
 - -
CH
Sun Pharmaceutical Industries Limited Sun Pharmaceutical Industries Limited
Sun Pharmaceutical Industries Limited
SUNPHARMA.NS
 $6.61B -
IN